Lithium in Bipolar Disorder: Renal Mechanisms, Nephrotoxicity Phenotypes, and a Shared-Care Pathway for Clinical Practice
International Journal of Molecular Sciences · 28.07.2026 · 27 (15) · 6730
DOI: 10.3390/ijms27156730 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.07.2026. Verfasst von Nikolina Rijavec und 1 weiteren Autor:innen. Beteiligte Einrichtung: University Psychiatric Clinic Ljubljana, Chengdujska cesta 45, 1260 Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Bipolar Disorder, Lithium, Lithium Compounds, Kidney. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Slovenian Research and Innovation Agency.
Abstract (Originalsprache)
Lithium remains a cornerstone mood stabilizer for bipolar disorder, with strong evidence for relapse prevention and a unique association with reduced suicide risk. Its benefit is counterbalanced by renal adverse effects, ranging from impaired urinary concentrating capacity and nephrogenic diabetes insipidus (NDI) to chronic tubulointerstitial nephropathy with progressive loss of glomerular filtration rate in a minority of long-term users. Mechanistically, lithium enters collecting duct principal cells via the epithelial sodium channel, disrupts vasopressin-regulated water handling by downregulating aquaporin-2, and can drive chronic interstitial injury. Risk is amplified by episodes of lithium intoxication, dehydration, interacting medications that reduce renal lithium clearance, longer treatment duration, and comorbid kidney disease. This review integrates psychiatric and nephrologic perspectives on lithium’s indications, mechanisms, renal phenotypes, and prevention strategies, and proposes a practical shared-care pathway for patients with bipolar disorder who develop polyuria, NDI, acute kidney injury, or chronic kidney disease during lithium therapy, emphasizing monitoring, targeted treatment of polyuria, mitigation of toxicity, and structured shared decision-making when renal function declines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Psychiatric Clinic Ljubljana, Chengdujska cesta 45, 1260 Ljubljana, Slovenia.
- Department of Psychiatry, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia.
- Department of Nephrology, University Medical Centre Ljubljana, Zaloška 2, 1000 Ljubljana, Slovenia.
- Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia.
ORCID-Profile: Nikolina Rijavec, Željka Večerić-Haler
Förderung
- The Slovenian Research and Innovation Agency
Zitieren
APA
Rijavec, N., & Večerić-Haler, Ž. (2026). Lithium in Bipolar Disorder: Renal Mechanisms, Nephrotoxicity Phenotypes, and a Shared-Care Pathway for Clinical Practice. International Journal of Molecular Sciences, 27(15), 6730. https://doi.org/10.3390/ijms27156730
Vancouver
Rijavec N, Večerić-Haler Ž. Lithium in Bipolar Disorder: Renal Mechanisms, Nephrotoxicity Phenotypes, and a Shared-Care Pathway for Clinical Practice. International Journal of Molecular Sciences. 2026;27(15):6730. doi:10.3390/ijms27156730
BibTeX
@article{Rijavec2026,
author = {Rijavec, Nikolina and Večerić-Haler, Željka},
title = {Lithium in Bipolar Disorder: Renal Mechanisms, Nephrotoxicity Phenotypes, and a Shared-Care Pathway for Clinical Practice},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {15},
pages = {6730},
doi = {10.3390/ijms27156730}
}
EUVIMED